Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
RORgammat 调节胸腺细胞发育和 Th17 di 的差异机制
基本信息
- 批准号:8635224
- 负责人:
- 金额:$ 42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectArthritisAutoimmune DiseasesAutoimmunityBiological ProcessCD4 Positive T LymphocytesCell MaturationCellsChromatinCollaborationsDataDevelopmentDiabetes MellitusDrug TargetingGene ExpressionGene TargetingGoalsHelper-Inducer T-LymphocyteImmune responseInterleukin-17Lymphoid TissueLymphomaMediatingModelingMolecular ProfilingMultiple SclerosisOrphanPeripheralPharmaceutical PreparationsPlayProcessProteinsRecruitment ActivityRegulationRoleSignal TransductionSignaling MoleculeStagingT cell differentiationT cell transcription factor 1T-Cell DevelopmentT-LymphocyteTestingTherapeuticThymic LymphomaThymocyte DevelopmentThymus GlandTretinoinWorkdrug developmentepigenetic markergenome-widein vivoinnovationmutantnovelpublic health relevancereceptorthymocytetooltranscription factor
项目摘要
Abstract
!
To become competent effector Th17 cells mediating the actual immune responses, T
cells have to undergo two ROR¿t-dependent differentiation processes sequentially
carried out in thymus and peripheral lymphoid tissues. ROR¿t is up-regulated in
thymocyes to enhance the survival required for completion of T cell maturation process
in thymus, and absence of ROR¿t activity severely impairs thymocyte development that
eventually leads to lymphoma. ROR¿t is again up-regulated in peripheral CD4+ T cells to
instruct the differentiation of Th17 cells that mediate many types of autoimmunity. ROR¿t
is thus considered an important drug target for treatment of Th17-dependent
autoimmunity. However, little is known about the common and distinct mechanisms that
ROR¿t utilize to regulate these two differentiation processes. Our goal is to understand
the function of ROR¿t in both thymocytes and Th17 cells, which will facilitate to develop
drugs specifically targeting Th17-dependent autoimmunity, but not interfering with
thymocyte development that leads to lymphoma. The objective of this application is to
understand how both thymocytes and peripheral T cells differentially use the same
transcription factor ROR¿t to regulate their differentiation processes.!
摘要
!
为了成为有能力的效应Th17细胞介导实际的免疫应答,T
细胞必须依次经历两个依赖ROR t的分化过程
在胸腺和外周淋巴组织中进行。ROR t在以下情况下上调:
胸腺细胞的生存,以提高完成T细胞成熟过程所需的
在胸腺中,ROR t活性的缺乏严重损害胸腺细胞的发育,
最终导致淋巴瘤ROR t在外周CD4+ T细胞中再次上调,
指导介导多种类型自身免疫的Th17细胞的分化。滚吧
因此被认为是治疗Th17依赖性
自身免疫然而,人们对这些共同和独特的机制知之甚少,
ROR不能用来调节这两个分化过程。我们的目标是了解
ROR t在胸腺细胞和Th17细胞中的功能,这将有助于发展
特异性靶向Th17依赖性自身免疫但不干扰
胸腺细胞发育导致淋巴瘤本申请的目的是
了解胸腺细胞和外周T细胞如何区别使用相同的
转录因子ROR?t来调节它们的分化过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zuoming Sun其他文献
Zuoming Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zuoming Sun', 18)}}的其他基金
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
RORgammat 调节胸腺细胞发育和 Th17 di 的差异机制
- 批准号:
9265772 - 财政年份:2014
- 资助金额:
$ 42万 - 项目类别:
Steroid nuclear receptor coactivators in T cell differentiation
T 细胞分化中的类固醇核受体共激活剂
- 批准号:
10597251 - 财政年份:2014
- 资助金额:
$ 42万 - 项目类别:
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
RORgammat 调节胸腺细胞发育和 Th17 di 的差异机制
- 批准号:
8810643 - 财政年份:2014
- 资助金额:
$ 42万 - 项目类别:
Steroid nuclear receptor coactivators in T cell differentiation
T 细胞分化中的类固醇核受体共激活剂
- 批准号:
10152513 - 财政年份:2014
- 资助金额:
$ 42万 - 项目类别:
Steroid nuclear receptor coactivators in T cell differentiation
T 细胞分化中的类固醇核受体共激活剂
- 批准号:
10392370 - 财政年份:2014
- 资助金额:
$ 42万 - 项目类别:
Dissecting PKC-theta-regulated T cell functions in allograft rejection
剖析 PKC-theta 调节的 T 细胞在同种异体移植排斥反应中的功能
- 批准号:
8123649 - 财政年份:2010
- 资助金额:
$ 42万 - 项目类别:
In vivo Analysis of RORgamma mediated Functions
RORgamma 介导功能的体内分析
- 批准号:
7623766 - 财政年份:2004
- 资助金额:
$ 42万 - 项目类别:
PKC-theta function in RORgammat-regulated Th17 differentiation
PKC-theta 在 RORgammat 调节的 Th17 分化中的功能
- 批准号:
8580188 - 财政年份:2004
- 资助金额:
$ 42万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别: